论文-万方医学网

1. Experimental ischemia/reperfusion model impairs endocannabinoid signaling and Na⁺/K⁺ ATPase expression and activity in kidney proximal tubule cells.

【外文期刊】 Luzia S,Sampaio ; Fabio A,Iannotti ; 等《Biochemical pharmacology》 2018年154卷 482-491页 SCIMEDLINECABP

【关键词】 AM251 (PubChem CID 2125); ATP (PubMed CID 124080954); Antimycin A (PubMed CID 16218979);

LinkOut

浏览：29 被引：0 下载：0

2. Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice.

【外文期刊】 Simon,Nicolussi ; Juan Manuel,Viveros-Paredes ; 等《Pharmacological research》 2014年80卷 52-65页 SCIMEDLINEBP

【关键词】 (+)-R-WIN 55,212-2 (PubChem CID: 5311501); 2-Arachidonoylglycerol (PubChem CID: 5282280); Anandamide (PubChem CID: 5281969);

LinkOut

浏览：44 被引：0 下载：0

3. Phenotypic screening of cannabinoid receptor 2 ligands shows different sensitivity to genotype.

【外文期刊】 Julia M,Hillger ; Beau,le Roy ; 等《Biochemical pharmacology》 2017年130卷 60-70页 SCIMEDLINECABP

【关键词】 2-AG (PubMed CID: 5282280); AEA (PubMed CID: 5281969); AM251 (PubMed CID: 2125);

LinkOut

浏览：31 被引：0 下载：0

4. Assessing the role of ghrelin and the enzyme ghrelin O-acyltransferase (GOAT) system in food reward, food motivation, and binge eating behavior.

【外文期刊】 Emanuela,Micioni Di Bonaventura ; Luca,Botticelli ; 等《Pharmacological research》 2021年172卷 105847页 SCIMEDLINEBP

【关键词】 Binge eating disorder (BED); D-AP5 (PubChem CID: 135342); Eticlopride (PubChem CID: 57267);

LinkOut

浏览：0 被引：0 下载：0

5. Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer's disease.

【外文期刊】 Attila,Köfalvi ; Cristina,Lemos ; 等《Neuropharmacology》 2016年110卷Pt A期 519-529页 SCIMEDLINECABP

【关键词】 10252734); 108223); 11507802);

LinkOut

浏览：46 被引：0 下载：0

6. Effect of synthetic cannabinoids on spontaneous neuronal activity: Evaluation using Ca(2+) spiking and multi-electrode arrays.

【外文期刊】 Joseph S,Tauskela ; Tanya,Comas ; 等《European journal of pharmacology》 2016年786卷 148-160页 SCIMEDLINECABP

【关键词】 AB-PINACA (PubMed CID: 71301472); CP 55,940 (PubMed CID: 104895); Ca(2+) spiking;

LinkOut

浏览：57 被引：0 下载：0

7. Characterization of the intrinsic activity for a novel class of cannabinoid receptor ligands: Indole quinuclidine analogs.

【外文期刊】 Lirit N,Franks ; Benjamin M,Ford ; 等《European journal of pharmacology》 2014年737卷 140-8页 SCIMEDLINECABP

【关键词】 CP-55,940 (PubChem CID: 104895); Cannabinoid type-1 receptor; Cannabinoid type-2 receptor;

OA

浏览：48 被引：0 下载：0

8. Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro.

【外文期刊】 Richard A,Slivicki ; Zhili,Xu ; 等《Pharmacological research》 2019年142卷 267-282页 SCIMEDLINEBP

【关键词】 4T1; Cannabinoid; Chemotherapy-induced neuropathic pain;

OA

浏览：8 被引：0 下载：0

9. Correlating FAAH and anandamide cellular uptake inhibition using N-alkylcarbamate inhibitors: from ultrapotent to hyperpotent.

【外文期刊】 Simon,Nicolussi ; Andrea,Chicca ; 等《Biochemical pharmacology》 2014年92卷4期 669-89页 SCIMEDLINECABP

【关键词】 (+)-R-WIN 55,212-2 (PubChem CID: 5311501); Anandamide (PubChem CID: 5281969); Anandamide transport;

LinkOut

浏览：12 被引：0 下载：0

检索历史清除

模糊

与

模糊

与

模糊

开始

结束

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

模糊

与

模糊

与

模糊

开始

结束

批量导出

批量导出

检索历史清除